To reduce the risks of drug development, KaiPharm, based in Seoul, South Korea, has developed KMAP, which combines artificial intelligence (AI) with transcriptome profiling to generate deep ...
The following is a summary of “A cross-tissue transcriptome-wide association study identifies new susceptibility genes for benign prostatic hyperplasia,” published in the January 2025 issue of Urology ...
Key Findings Enabled by PacBio Technology: Synchronized Multiomic Sequencing: For the first time, a single sequencing run provided simultaneous insights into genome, methylome, epigenome, and ...